Tag:
value-based drug pricing
Latest Headlines
Latest Headlines
Feds to test new Medicare Part B payment models
Citing a new report that found prescription drug spending reached $457 billion in 2015, the federal government announced it will test new Medicare Part B payment models to try to tackle those spiraling costs.
Novartis' deal with insurers could signal new wave of drug pricing
The recent performance-based deal that Novartis cut with two insurance giants could signal the beginnings of a new approach to drug pricing, according to a Bloomberg editorial.
How payers, drug companies can partner to further value-based payments
While they sometimes have opposing interests, payers and drug companies can work together so that patients have better access to new, innovative medications, according to a Health Affairs Blog post.
